compound 12 [PMID: 31990537]   Click here for help

GtoPdb Ligand ID: 10664

Synonyms: example 24 [WO2014042939A1]
Compound class: Synthetic organic
Comment: Compound 12 is reported as a reversible inhibitor of endothelial lipase [1]. It is active in vivo, elevating plasma HDL-cholesterol levels in a mouse pharmacodynamics model. The chemical structure is claimed in Bristol-Myers Squibb's patent WO2014042939A1 [2]. Compound 12 is a tool compound that is suitable to help establish proof-of-concept for pharmacological inhibition of EL as a alternative mechanism to raise HDL-cholesterol levels as a route to clinical cardiovascular benefit.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 177.69
Molecular weight 415.04
XLogP 2.04
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1nc2c(s1)cc(cc2)c1ccccc1)c1nnc(o1)CNS(=O)(=O)N
Isomeric SMILES O=C(c1nc2c(s1)cc(cc2)c1ccccc1)c1nnc(o1)CNS(=O)(=O)N
InChI InChI=1S/C17H13N5O4S2/c18-28(24,25)19-9-14-21-22-16(26-14)15(23)17-20-12-7-6-11(8-13(12)27-17)10-4-2-1-3-5-10/h1-8,19H,9H2,(H2,18,24,25)
InChI Key LXSODRTWQNWTOG-UHFFFAOYSA-N
Bioactivity Comments
Compound 12 inhibits recombinant human hepatic lipase (lipase C; LIPC) in a fluorogenic substrate assay with an in vitro IC50 of 2 nM. When human serum is added to this assay, the IC50 for EL is increased from 5 nM to 100 nM.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
lipase G, endothelial type Hs Inhibitor Inhibition 8.3 pIC50 - 1
pIC50 8.3 (IC50 5x10-9 M) [1]
Description: Determined in a fluorogenic substrate assay using recombinant human EL.